Striving for Chemical, Biological & Radiation Safety, Leadership Buy-In & Sustainable Waste Management
Returning to Boston in 2026, the 3rd Annual EHS in Biopharma Summit is the only industry-specific meeting on the East Coast dedicated to uniting Global, Corporate, Vice President and Director-level Environment, Health & Safety leaders across biotech, pharma, CROs and CDMOs.
As the biopharma industry continues its rapid expansion, driven by the rise of radiopharmaceuticals, antibody-drug conjugates, cell and gene therapies, and novel vaccines, EHS professionals are under mounting pressure to scale safety systems, mitigate new biological and chemical risks, and embed sustainability into operations. This year’s meeting provides the strategic foresight and technical depth needed to support this transformation, ensuring zero serious injuries and fatalities in increasingly complex R&D and manufacturing settings.
Join senior EHS decision-makers from Sanofi, AbbVie, Biogen, AstraZeneca, Charles River Laboratories, Novartis, Jackson Laboratories, Ultragenyx, Genentech, and more to connect, collaborate, and benchmark your strategies against industry leaders tackling the same challenges.
What Makes this Summit Unique
Built for Biopharma
The only event exclusively focused on EHS within drug development, connecting experts managing risk across R&D and manufacturing environments.
Strategic and Technical Depth
A balanced agenda for VPs and Global Heads shaping long-term EHS strategy and Directors and Specialists driving implementation and innovation.
Timely & Transformative
As new drug modalities reshape facility design, safety standards, and environmental priorities, this summit empowers EHS leaders to de-risk innovation and enable sustainable growth.
The brochure is the fastest way to understand whether this summit is right for you or your team. Inside, you’ll find:
- A full, side-by-side view of the agenda, including parallel workshops for site-level leaders and global EHS directors
- Confirmed speakers and up-to-date bios from organisations such as Amgen, AbbVie, Sanofi, AstraZeneca, Biogen, Genentech, Novartis, Charles River Laboratories, and more
- Session-level detail outlining exactly what you’ll learn, who it’s for, and how it applies to your role
- Clear breakdowns you can share internally to support approval, budget sign-off, or team attendance decisions
Download the brochure to review the full agenda, speaker faculty, and session focus in one place.
Attending Companies Include